Cargando…
The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.
Apoptosis can be triggered by cytotoxic agents and radiation currently used in cancer treatment. However, the apoptotic response appears to vary between cell types (normal or transformed) and between types of malignancy. Thus, irradiation induces apoptosis in normal human lymphocytes but not in lymp...
Autores principales: | Delic, J., Masdehors, P., Omura, S., Cosset, J. M., Dumont, J., Binet, J. L., Magdelénat, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150120/ https://www.ncbi.nlm.nih.gov/pubmed/9569046 |
Ejemplares similares
-
Lactacystin: first-in-class proteasome inhibitor still excelling and an exemplar for future antibiotic research
por: Ōmura, Satoshi, et al.
Publicado: (2019) -
Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells
por: XU, YE, et al.
Publicado: (2015) -
Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
por: Pierga, J. Y., et al.
Publicado: (1997) -
Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance.
por: Williamson, K. E., et al.
Publicado: (1998) -
T lymphocyte apoptosis in asthma
por: Potapinska, O, et al.
Publicado: (2009)